In patients with GRIA2-related disorders, NDD is often associated with a number of additional clinical features, including neurological and psychiatric comorbidity and other systemic signs, implying that affected individuals should have regular neurological and neuropsychiatric assessments. This evidence concerns the gene GRIA2 and Neurodevelopmental delay.